Therefore, further research is needed on which of the BAFF/BAFF-R pathway or the BAFF/TACI pathway is more suitable for acute GVHD using BAFF-R and TACI conditional knockout mice or BAFF-R or TACI blockage antibodies. This evidence concerns the gene TNFSF13B and acute graft versus host disease.